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A B S T R A C T
Cervical cancer is the second most common female malignancy in Serbia, after breast cancer, with 1089 new regis-
tered cases and an age-standardized incidence rate of 27.2 per 100,000 women in 2002. It is the fourth leading cause of
cancer death with 452 deaths and an age-standardized death rate of 7.2 per 100,000 women. Compared with other Euro-
pean countries, the incidence of cervical cancer in Central Serbia is the highest. Regional differences in incidence are
pronounced in Serbia with the lowest age-standardized incidence rate (16.6 per 100,000 women) registered in the Ma~-
vanski region and the highest in eastern Serbia and the region of Belgrade where the rates are double at 32.5–38.1 per
100,000 women. Cervical cancer prevention in Serbia has relied on opportunistic screening that is characterized by high
coverage in younger and low coverage in middle-aged and older women. Screening of selected groups of women em-
ployed in large companies is performed annually by many regional hospitals but this approach has little effect on mor-
bidity and mortality. Recently, the Ministry of Health nominated an Expert Group to develop and implement a national
cervical cancer screening program. A number of pilot projects have been undertaken with the results used for develop-
ment of a national programme for cervical cancer screening. This is expected to be finalized in 2007, and launched over a
3-years period in order to cover all women aged 25–64 in entire Serbia.
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Introduction
The aim of the present study was evaluate the burden
of cervical cancer in Serbia and present the status of cer-
vical cancer prevention. The sources used to develop this
report were official the Statistical Office of Serbia and
the Cancer Registry of Serbia, as well as the results of
the studies and projects related to cervical cancer screen-
ing conducted in Serbia during the period of 2002–2007.
Global Situation
Cervical cancer is the second most common malig-
nancy in women worldwide, with about 490,000 newly
registered cases every year. There are large differences in
the incidence rate which varies from 2.0 per 100,000
women in Syria to 87.3 per 100,000 women in Haiti (age
standardized rates). The highest rates are observed in
Eastern and Southern Africa, Melanesia, Caribbean and
Central America; the lowest rates are observed in East-
ern and Western Asia, Australia, Northern America,
Northern and Western Europe1.
Several factors contribute to regional differences in
cervical cancer rates and their trends. Persistent infec-
tions with the Human papillomavirus (HPV) are a neces-
sary but not sufficient cause of cervical cancer. HPV is
primarily transmitted by sexual contanct but differences
in sexual behavior cannot entirely account for the geo-
graphic variation in cervical cancer. The most important
factor is the availability of screening. In many developed
countries where screening has been in place for a num-
ber of years, a decline in cervical cancer incidence and
mortality has been observed over the last 30 years.
Cervical Cancer – a Major Health
Problem in Serbia
From 1973–1982, the European extremes in cervical
cancer incidence were the German Democratic Republic
with an incidence of 33.2 and Spain with the one of 4.12.
At that time, the incidence in regions of Central Serbia
where the cancer registries were functioning properly
was 14.7 to 18.2 per 100,0003.
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In 1995, the cancer registry in Central Serbia was re-
organized with all new cases from Serbia’s 16 regions
registered centrally and the average age-standardized in-
cidence rate for 1999 was 20.8/100,000 while the average
standardized incidence rate for the European Union was
9.94. Today, according to the data of the Cancer Registry
of Central Serbia, cervical cancer is the second most com-
mon female malignancy after breast cancer with 1,089
new cases per year and the age-standardized incidence
rate of 27.2 per 100,000 women in the year 20025. How-
ever, there are also significant differences in cervical can-
cer incidence between the regions of Central Serbia (Fig-
ure 1). In 2002, the lowest age-standardized incidence
rate (16.6 per 100,000 women) was registered in the
Ma~vanski region. The highest rates, more than twice
higher, were registered in eastern Serbia, near the border
with Romania, and in the region of Belgrade (32.5–38.1
per 100,000 women)5.
When compared with data from European countries,
the incidence of cervical cancer in Central Serbia is the
highest in Europe. Similar high rates are observed in
neighboring countries such as Romania, Albania and
Bosnia & Herzegovina (Figure 2).
In 2002, according to the data of the Statistical Office
of Serbia, cervical cancer was the fourth leading cause of
cancer death in females in Serbia with 452 deaths and
the age-standardized death rate of 7.2 per 100,000 wo-
men5. As for mortality, Romania is the country with the
highest mortality rate in Europe, while Serbian rate is
significantly lower (Table 1). However, cervical cancer
mortality depends on incidence and survival rates. As
both Serbia and Romania have similar high incidence
rates, difference in mortality could be explained by better
availability and efficacy of cervical cancer treatment ser-
vices in Serbia.
Age Distribution of Cervical Cancer
in Serbia
The risk for cervical cancer increases with age. In
Central Serbia very few cases are diagnosed before the
age of 25. After that age, the incidence increases and
reaches maximum in the 45 to 49 and 50 to 54 age
groups6 (Table 2).
Potential Target Population for Cervical
Cancer Screening
Decisions on the target age group and frequency of
screening are usually made at the national level, on the
basis of local incidence and prevalence of cancer, HIV
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Fig. 1. Age-standardized cervical cancer incidence rates in Serbia,
by regions, (per 100,000 women); average 27.3/100,000 women-
-year. Source: Cancer Registry of Serbia, 20026.
Fig. 2. Age-standardized cervical cancer incidence rates in European
countries (per 100,000 women). Source: Ferlay J et al. Globocan
20021.
TABLE 1
COUNTRIES WITH HIGHEST CERVICAL CANCER MORTALITY
RATES IN EUROPE (AGE-STANDARIZED MORTALITY RATES PER
100,000 WOMEN IN 2002)
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prevalence, availability of resources and infrastructure.
WHO recommends that new programmes should start by
screening women aged 30 years and more, and include
women 25 to 29 only when the higher risk groups have
been covered. Screening should not include women un-
der 25 and for women over 65, screening is not necessary
if they have had two previous negative smears7.
The incidence of cervical cancer is high in all age
groups from 35 to 69. The upper age limit of the target
group should be set at least at the age of 64 so that there
would not be many cases missed by screening in older age
groups. On the other hand, lower age limit should be set
at 30 so that as many lesions as possible would be discov-
ered in precancerous lesions.
There is about 1,5 million women in the age group 30
to 59 and about 1,8 million women in the age group 30 to
64 in Serbia. With a three year interval, it would mean
0,5 or 0,6 million to be screened yearly.
Cervical Cancer Control Programme
A comprehensive, centalized screening programme
for cervical cancer has never been implemented in Serbia
and cervical cancer prevention has relied on opportunis-
tic screening. This type of screening has been character-
ized by high coverage in younger and low coverage in
middle-aged and older women. Screening of selected
groups of women employed in large companies is per-
formed annually by many regional hospitals. This ap-
proach, however, has had little effect on morbidity and
mortality.
In spite of some efforts to initiate screening during
the period between 1990 and 1999, the difficult situation
in the country did not enable more organized approach.
Besides the other effects on health service, the economic
crisis left significant the consequences to general health:
• Economic resources for health were lowered.
• Investments for health were decreased (from  150 per
person in 1997 to less than  50 in 1999).
• Prevention became inadequate.
• Overall mortality and morbidity increased.
In this situation, disease prevention through mass
screening in central Serbia did not seem to be the pri-
mary problem and cervical cancer control in Serbia had
unsatisfactory levels of effectiveness. This was primarily
due to the absence of national strategy for cancer preven-
tion, a lack of programme funds for cancer prevention or
early detection, as well as an insufficient public and polit-
ical awareness of the importance of cancer prevention.
Primary prevention programs did exist but were carried
out without well-defined methodology or objectives and
without appropriate effectiveness analysis. As a conse-
quence, a high proportion of cervical cancers were diag-
nosed when already well-advanced and metastatic, lead-
ing to a low probability of cure and high mortality rates.
Actions Against Cervical Cancer –
Preparing the Foundation for Organised
Cervical Cancer Screening
Beginning in the year 2000, the basic strategies ap-
plied to achieve the cervical cancer control in Serbia were
focused on cancer prevention and early detection strate-
gies. The main risk factors on the national level were de-
fined and monitored. The efforts were made to improve
the system for cancer registration. This could not be
achieved without introduction of unique information
system to help in overcoming communication problems
on the local, regional and national level. To achieve these
goals it was mandatory to increase the support of govern-
ment, as well.
Becoming aware of the increasing incidence and mor-
tality of cervical cancer in Serbia and the importance of
early detection and treatment of this disease, the Minis-
try of Health nominated an Expert Group for the preven-
tion and early detection of cervical cancer in 2003. The
aim was to develop and implement national screening
programme. It was expected that the systematic screen-
ing of non-symptomatic women would increase the pro-
portion of localized tumors, but also the need of treat-
ment resources for these cancers.
As a result, several projects have been completed to
study the psycho-social aspects of cervical screening in
this region and to improve the local screening infrastruc-
ture:
• A study conducted by the Institute of International So-
cial Affairs in 2002 showed that an educational cam-
paign on the importance of screening can increase par-
ticipation by more than 60%8.
• A survey sponsored by the Alliance for Cervical Cancer
Prevention (ACCP) and conducted by Programme for
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TABLE 2
AGE DISTRIBUTION OF CERVICAL CANCER CASES
IN CENTRAL SERBIA
Age group No of cases % of all cases Age specific rate
0–14 0 0 0
15–19 1 0.1 0.6
20–24 1 0.1 0.6
25–29 23 2.3 12.4
30–34 40 4 22.7
35–39 75 7.5 42.9
40–44 108 10.8 56.7
45–49 162 16.1 75.3
50–54 173 17.2 77.9
55–59 105 10.5 66.3
60–64 89 8.9 55.4
65–69 93 9.3 52.2
70–74 77 7.7 46.5
75+ 57 5.7 29.5
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Appropriate Technology in Helath (PATH) in 2003–4,
explored women’s knowledge and perceived barriers
towards cervical screening, so adequate campaigns can
be designed.
The research was focused on urban women residing in
the capital city and one major regional city. The study
was comprised of qualitative (phase I) and quantitative
(phase II) research. The main determining factors were
the age and education of the women. The first phase has
been realized through focus group discussions (62 wo-
men participated, recruited by network sampling) and
in-depth interviews (conducted with 22 women)9. Data
deriving from the qualitative study were used to develop
a questionnaire on women’s understandings and knowl-
edge of cervical cancer. The survey was distributed to 800
women from a selected number of community health
services10.
The population sampled showed a broad lack of know-
ledge about the necessity of screening and shared attitu-
dinal barriers with women in other regions. Results re-
vealed that most of women do not regularly visit a
gynaecologist, do not understand the purpose of Pap
smear (even if they regularly have it), think that absence
of symptoms means that they are healthy and do not
need Pap smear, do not know the procedure of Pap smear,
are often embarrassed about being examined (this was
independent of the gynecologist’s sex), believe that little
can be done to prevent cancer and an unwillingness to
talk about the illness. Education and economic status
were not highly related to knowledge about cervical
screening10.
Thematic analysis identified that the interplay of so-
cial and personal barriers influenced women’s poor pre-
sentation for screening. It found that the socio-economic
situation prevented women from focusing on their health
and it identified a number of problems with the delivery
of health services in the region. Inadequate public health
education, lack of patient-friendly health services, socio-
-cultural health beliefs, gender roles, and personal diffi-
culties were the most salient barriers to screening9.
The study findings suggest how, within the context of
opportunistic screening, patient education maybe em-
ployed. The introduction of compulsory cervical cancer
screening, suggested by some participants, may be a pos-
sible approach9. The success of public awareness cam-
paigns elsewhere suggests that a media-centered ap-
proach could also have good results in Serbia. The lack of
media attention noted in the study focus groups supports
this conclusion.
In general, study findings was used to inform and fa-
cilitate the change in government’s policy regarding cer-
vical screening and to develop the public health cam-
paign targeting cervical cancer.
• Clinical Center of Serbia was one of the partners in
European Consortium for Cervical Cancer Education
(ECCCE) project granted by European Commission
and conducted from 2002–2004. This project has lead
to the foundation of The European Cervical Cancer As-
sociation (ECCA). The ECCA was founded by 15 differ-
ent organisations from across Europe, which included
cancer charities, cancer treatment centres, university
teaching hospitals and health education organisations.
One of them was Clinical Center of Serbia. The ECCA
was established specifically to co-ordinate a Europe-
-wide public health education programme that would
raise awareness of cervical cancer and how it can be
prevented. For the general public in Serbia the project
was developing an educational programme to provide
women with the information they need to reduce their
risk of cervical cancer. This project has adopted the
materials developed by ECCCE and ECCA. These ma-
terials are approved by Serbian Ministry of Health and
widely distributed in Serbia through the network of re-
gional health centres.
• Project »Improving Preventive Health Services in Ser-
bia« (IPHSS) has started in September 2004. Its goal
was to reduce the mortality by improving preventive
health services. To achieve it, this project, funded by
European Union, managed by European Agency for
Reconstruction and realised by EPOS Health Consul-
tants, targets both health professionals and women.
IPHSS edited guidelines for prevention of cervical car-
cinoma elaborated in line with EU recommendations
and will distribute them in 25 regional Serbian health
centres11. It also supports the establishment of a na-
tional School for cytology. In parallel, IPHSS wishes to
contribute to the education of women on the preven-
tion of cervical cancer.
• A Pilot Programme for Cervical Cancer Screening was
implemented 2004 in Branicevo, a region in eastern
Serbia with a particularly high incidence of cervical
cancer12. This project, supported by the French gov-
ernment and implemented by WHO, was the first orga-
nized screening programme in Serbia.
Screening Implementation
»Branicevo project« was the first organized screening
in Serbia. In 2001, the French donor, the WHO and
health authorities of the Republic of Serbia jointly agre-
ed that the high mortality and incidence of cervical can-
cer in Serbia presents a major public health problem that
needs urgent intervention. The French donor approved a
grant for implementation of a pilot project for organized
screening of cervical cancer that would serve as a basis
for developing a national programme. The project man-
agement was entrusted to WHO Regional Office for Eu-
rope – WHO Country Office in Serbia (at the time Serbia
and Montenegro) and was planned for implementation
through the national health system (public health insti-
tutes and health service).
The project went through the following phases:
• Design of social mobilisation, action plan and imple-
mentation of social mobilisation.
• Setting up the Central Cytology Laboratory and the
quality assurance system for cervical screening.
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• Developing the Information Technology (IT) for scre-
ening.
• Training in software application and continuous on-
-site IT support.
• Regular weekly quality assurance visits to cytological
laboratory.
• Setting up monitoring and evaluation system.
• Drafting of national strategy – process support.
Screening invitations were sent to 22,300 women
aged 30–49 years in the Branicevo district and 12,763
women were screened. Sixty three high-grade squamous
intraepithelial lesion (H-SIL) and 6 invasive cancers
were detected in the screened population with the esti-
mated cervical cancer incidence of 47.01 per 100,000 and
49.36 H-SIL lesions per 100,000 women (Table 3).
The specific project objectives were achieved:
• 60 % of target population (women aged 30–49 years of
age) in the Branicevo district were screened for cervi-
cal cancer with cytological methods.
• Local Health experts were trained in methods of cyto-
logical screening and a system of quality assurance
was set up.
• Bethesda system of cytological classification was suc-
cessfully introduced into the practice.
• 16 % of all slides were re-screened through quality as-
surance system, all slides with positive findings at first
screening and 10 % of slides assessed as negative at
first screening.
• 95 % of matching between 1st and 2nd screening was
identified.
• 1.32 % of slides were inadequate for cytology and had
to be repeated.
• All women identified with pre-malignant lesions through
the screening project were referred for full diagnostic
procedure and required treatment.
• Effects of the pilot project on mortality for cervical
cancer screening in the district will be monitored but
will be visible only after a longer time period.
Conclusions
The results and experiences from the Branicevo pilot
project have been used for development of a National
programme for cervical cancer screening, which is ex-
pected to be finalized in 2007, and launched over a
3-years period in order to cover all Serbian women aged
25–64.
The development of national strategy is essential for
the sustainability of the effects of the project in the pilot
district and in Serbia in total. The Ministry of Health of
Serbia had set up a National Committee for Prevention
of Cervical Cancer, in July 2006. WHO will continue to
provide technical support to the National Committee in
2007 (through its regular programme) until a National
Programme for Cervical Cancer Screening and action
plan for nation wide implementation over a 3-years pe-
riod are fully developed.
In addition to supporting the development of the Na-
tional Programme, the WHO also supported the National
Cancer Registry so they were able to update the national
cancer data-base. It is expected that in 2007, the Na-
tional Cancer Registry will be able to start to monitor
pre-malignant lesions of the cervix (from the pilot dis-
trict) and when a national programme starts to be imple-
mented to monitor pre-malignant cervical lesions nation
wide. The Institute of Public Health (IPH) has been spe-
cifically supported to strengthen the Cancer Registry De-
partment and to prepare and print Annual Cancer Regis-
tries for 2002 and 2003 (2004 and 2005 were prepared as
well and will be published with internal resources of the
IPH of Serbia in 2007).
At the end of 2006 the process of development of a Na-
tional Programme for Cytological Screening of Cervical
Cancer and preparing of a national action plan is fully
under way. However, the operationalisation of the Pro-
gramme and its implementation will depend on integrati-
on of this new public health programme into the financing
mechanisms of the Serbian health system (combination
of the national health insurance for individual services
and Ministry of Health budget for the support to the pub-
lic health component – social mobilisation, organisation
of programme, programme monitoring and implementa-
tion).
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TABLE 3
THE DISTRIBUTION OF CERVICAL SMEAR RESULTS IN THE SCREENED POPULATION OF BRANICEVO REGION





PAP IV PAP V Unsatisfacotry Total
Number of women examined 554 11057 520 340 94 26 4 168 12,763
% 4.34 86.63 4.08 2.66 0.74 0.20 0.03 1.32 100.00
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PROBIR RAKA VRATA MATERNICE U SRBIJI
S A @ E T A K
Rak vrata maternice zauzima drugo mjesto me|u bolestima `ena u Srbiji, odmah iza raka dojke, sa 1.089 regis-
triranih novih slu~ajeva te dobno-standardiziranom stopom pojavnosti od 27,2 na 100.000 `ena u 2002. g. Na ~etvrtom
je mjestu po smrtnosti sa 452 smrtna slu~aja te dobno-standardiziranom stopom smrtnosti od 7,2 na 100.000 `ena. U
usporedbi s ostalim europskim zemljama pojavnost raka vrata maternice u Centralnoj Srbiji je najvi{a. Regionalne
razlike u pojavnosti ovog raka su jako izra`ene u Srbiji, sa najni`om dobno-standardiziranom stopom pojavnosti (16,6
na 100.000 `ena) zabilje`enom u podru~ju Ma~vanski, a najvi{om u isto~noj Srbiji te podru~ju Beograda gdje su stope
pojavnosti dvostruko vi{e (32,5–38,1 na 100.000 `ena). Prevencija raka vrata maternice u Srbiji se temelji na opor-
tunisti~kom probiru koji je karakteriziran visokom pokrivenosti mladih te niskom pokrivenosti starijih i `ena srednjih
godina. Probir odabranih skupina `ena zaposlenih u velikim tvrtkama se provodi u mnogim podru~nim bolnicama
jednom godi{nje, me|utim ovaj pristup ima mali utjecaj na bolest i smrtnost. Nedavno je Ministarstvo zdravstva ime-
novalo Grupu stru~njaka koja bi razvila i provela program probira raka vrata maternice na nacionalnoj razini. Provodi
se velik broj pilot-projekata rezultati kojih se koriste za razvoj nacionalnog programa probira za rak vrata maternice.
O~ekuje se da }e to biti dovr{eno u 2007. g. te, kroz razdoblje od 3 godine, pokretanje programa probira koji bi pokrivao
sve `ene Srbije u dobi izme|u 25 i 64 godine.
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